Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett
Steven L Teitelbaum

Showing results (231-240 of 1,160) with videos related to

Pageof 116
Sort By:
The Journal of Biological Chemistry|November 24, 2001
Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signalingShi Wei, Michael W-H Wang, Steven L Teitelbaum, et al.
Journal of Cellular Biochemistry|November 19, 2003
High dose M-CSF partially rescues the Dap12-/- osteoclast phenotypeRoberta Faccio, Wei Zou, Graziana Colaianni, et al.
The Journal of Biological Chemistry|September 5, 2008
Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclastsShuting Bai, Jikun Zha, Haibo Zhao, et al.
Deutsches Arzteblatt International|April 4, 2019
Checkpoint InhibitorsLucie Heinzerling, Enrico N de Toni, Georg Schett, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT studyStephanie Finzel, Juergen Rech, Sarah Schmidt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritisStephanie Finzel, Enijad Sahinbegovic, Roland Kocijan, et al.
Frontiers in Immunology|September 13, 2012
Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cellsChristine Schorn, Christina Janko, Melanie Latzko, et al.
Rheumatology (Oxford, England)|August 18, 2022
Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world settingBenjamin Birkner, Jürgen Rech, Edmund Edelmann, et al.
The Lancet. Rheumatology|March 20, 2026
Effects of abatacept for those at high risk of rheumatoid arthritisUlrike Steffen, Koray Tascilar, Milena Santopietro, et al.
Zeitschrift Fur Rheumatologie|June 23, 2023
Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritisBenjamin Birkner, Jürgen Rech, Edmund Edelmann, et al.
Pageof 116

Showing results (231-240 of 1,160) with videos related to

Sort By:
Pageof 116
The Journal of Biological Chemistry|November 24, 2001
Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signalingShi Wei, Michael W-H Wang, Steven L Teitelbaum, et al.
Journal of Cellular Biochemistry|November 19, 2003
High dose M-CSF partially rescues the Dap12-/- osteoclast phenotypeRoberta Faccio, Wei Zou, Graziana Colaianni, et al.
The Journal of Biological Chemistry|September 5, 2008
Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclastsShuting Bai, Jikun Zha, Haibo Zhao, et al.
Deutsches Arzteblatt International|April 4, 2019
Checkpoint InhibitorsLucie Heinzerling, Enrico N de Toni, Georg Schett, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT studyStephanie Finzel, Juergen Rech, Sarah Schmidt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritisStephanie Finzel, Enijad Sahinbegovic, Roland Kocijan, et al.
Frontiers in Immunology|September 13, 2012
Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cellsChristine Schorn, Christina Janko, Melanie Latzko, et al.
Rheumatology (Oxford, England)|August 18, 2022
Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world settingBenjamin Birkner, Jürgen Rech, Edmund Edelmann, et al.
The Lancet. Rheumatology|March 20, 2026
Effects of abatacept for those at high risk of rheumatoid arthritisUlrike Steffen, Koray Tascilar, Milena Santopietro, et al.
Zeitschrift Fur Rheumatologie|June 23, 2023
Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritisBenjamin Birkner, Jürgen Rech, Edmund Edelmann, et al.
Pageof 116